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Purpose To evaluate the effect of media composition
and storage method on pre-prepared Descemet’s
membrane endothelial keratoplasty (DMEK) grafts.
Methods 50 corneas were used. Endothelial wound
healing and proliferation in different media were
assessed using a standard injury model. DMEK grafts
were stored using three methods: peeling with free scroll
storage; partial peeling with storage on the stroma and
ﬂuid bubble separation with storage on the stroma.
Endothelial cell (EC) phenotype and the extent of
endothelial overgrowth were examined. Global cell
viability was assessed for storage methods that
maintained a normal cell phenotype.
Results 1 mm wounds healed within 4 days. Enhanced
media did not increase EC proliferation but may have
increased EC migration into the wounded area. Grafts
that had been trephined showed evidence of EC
overgrowth, whereas preservation of a physical barrier in
the bubble group prevented this. In grafts stored in
enhanced media or reapposed to the stroma after
trephination, endothelial migration occurred sooner and
cells underwent endothelial-mesenchymal transformation.
Ongoing cell loss, with new patterns of cell death, was
observed after returning grafts to storage. Grafts stored
as free scrolls retained more viable ECs than grafts
prepared with the ﬂuid bubble method (74.2± 3% vs
60.3±6%, p=0.04 (n=8).
Conclusion Free scroll storage is superior to liquid
bubble and partial peeling techniques. Free scrolls only
showed overgrowth of ECs after 4 days in organ culture,
indicating a viable time window for the clinical use of
pre-prepared DMEK donor material using this method.
Methods for tissue preparation and storage media
developed for whole corneas should not be used in pre-
prepared DMEK grafts without prior evaluation.
INTRODUCTION
While new modalities show promise,1 at present,
the only effective treatment for corneal endothelial
dysfunction is transplantation. Isolated transplant-
ation of the corneal endothelium with just its base-
ment membrane, Descemet’s membrane endothelial
keratoplasty (DMEK), is a successful and increas-
ingly popular treatment option. There is mounting
evidence that DMEK may have inherent advantages
over Descemet’s stripping endothelial keratoplasty
(DSEK) in terms of visual recovery,2 ﬁnal acuity
and rejection risk.3 4 However, current evidence
suggests that postoperative cell loss may be higher
in DMEK than other forms of endothelial kerato-
plasty (EK) and this is likely to have a bearing on
graft survival.5–7
While the number of DMEK procedures per-
formed has increased over the past 5 years, it is yet
to overtake DSEK, which remains the predominant
form of EK in the USA.8 One of the reasons for
the slow adoption of DMEK is fear of tissue
wastage during preparation.9 Delivery of eye bank-
prepared DMEK grafts might ease the learning
curve and likely increase the adoption of DMEK,
as it did for Descemet’s stripping automated EK
(DSAEK).10 Pre-preparation of graft tissue should
therefore focus on minimising tissue wastage and
ensuring that the transplanted tissue has the highest
possible global endothelial cell density (ECD).
The endothelium of whole corneas has been well
characterised after body temperature (31°C–37°C)
storage—the system used widely across Europe.
Changes in ECD during storage, endothelial
wound healing,11 the spatial patterns of cell death
and tight junction morphology have been evalu-
ated.12 13 This means that surgeons preparing
DMEK grafts in theatre can be relatively assured of
the quality and phenotype of the endothelial cells
(ECs) being transplanted. However, little is known
about how the corneal endothelium/Descemet’s
membrane (DM) complex behaves once separated
from the stroma and returned to storage. We have
shown that DMEK grafts carry over non-viable
cells from the original period in culture, with
further damage occurring from trephination and
tissue handling.14 The second period of graft
storage after DMEK preparation presents an oppor-
tunity to adjust media and storage conditions,
enhancing wound healing and perhaps shortening
the postoperative recovery period.
Strategies to improve endothelial wound healing
and endothelial survival in whole corneas have
included using serum,15 limiting storage time,16
changing media half way through the storage
period and supplementing with peptide growth
hormones known to be produced by the corneal
keratocytes and epithelium.17–20 It is possible that
grafts remaining attached to the stroma have
improved viability and better wound-healing prop-
erties if a form of co-culture exists, and for those
stored as free scrolls, enhancing the culture media
with growth hormones may be beneﬁcial, as it is
for EC culture.21
We hypothesised that a serum and growth factor-
supplemented organ culture media would be bene-
ﬁcial for preserving ECD and for promoting
wound healing in DMEK grafts. The composition
of this media was optimised in a porcine primary
EC culture model in a manner similar to previously
published work.22 In pilot experimentation, we
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observed a phenomenon of endothelial migration onto the
stromal surface of DMEK grafts that were returned to culture
after material preparation, a feature that, to our knowledge, has
not been reported before. The degree of overgrowth and time
period to ﬁrst observation varied with the media and different
storage methods and we systematically evaluated this in further
experimentation.
We subsequently compared three contemporary methods for
storing pre-prepared DMEK grafts. In method 1, the grafts are
peeled off completely and shipped as a scroll in a glass phial
containing organ culture ﬂuid. This method is employed by the
Amnitrans EyeBank in Rotterdam.23 In method 2, the grafts are
peeled 90% off and then laid back on the stroma prior to trans-
plantation.24 This is the predominant method followed in US
eye banks working with cold storage media and has also been
adopted by the Venice eye bank in an organ culture system. In
method 3, also described by the Venice eye bank, the DM is
separated from the stroma by creating a ﬂuid bubble and then
shipped with or without removing the stroma.25 26
To our knowledge, no systematic comparison of global EC
viability for these different storage techniques has been con-
ducted, with most published studies reporting results of ECD
changes in small high power ﬁelds.26–28 We previously described
a technique to map the viability of every cell in DMEK trans-
plants that fully account for graft curvature, wound healing, any
proliferation and ongoing cell loss.14 We used this method to
show that a peel technique was superior to a ﬂuid bubble
method in terms of endothelial viability for tissue prepared
immediately prior to use. In this study, we evaluated all three
storage methods to determine if there were any differences in
cell phenotype or global viability after storage of pre-prepared
grafts.
METHODS
A graphical representation of the sequence of experimentation
is presented in ﬁgure 1. The study protocol was approved by
the institutional review board at the Institute of Ophthalmology,
University College London, Bath Street, London, UK. All proce-
dures conformed to the tenets of the Declaration of Helsinki
for biomedical research involving human tissues.
Study tissue
Human corneoscleral buttons with consent for research use
were obtained from Miracles in Sight (Winson Salem, North
Carolina, USA) and UKTS Eye Banks (Bristol, UK). Tissue prep-
aration and experimentation was performed by a single surgeon
(Maninder Bhogal) with experience of >150 DMEK tissue
preparations.
Tissue used for the wound healing and the initial endothelial
overgrowth experiments had a minimum ECD of 1600 cells/mm2
and had been stored in organ culture for no longer than
5 weeks (media changed at week 4). Transplant grade tissue with
EC counts of >2200 cells/mm2 and a storage time <14 days in
Optisol GS (Bausch & Lomb Rochester, New York, USA) was
used for global endothelial viability assessment and conﬁrmatory
experiments of EC overgrowth using whole corneas. In experi-
ments comparing two variables, either the tissue was divided or
paired tissue was used, with one whole cornea from each pair
being assigned to each intervention, minimising the effects of
donor variation.
Initial cell density measurement was performed in the eye
bank supplying the tissue using either specular (Optisol) or
bright ﬁeld (organ-cultured tissue) microscopy. Each cornea was
examined for gross cell death prior to experimentation by stain-
ing with 0.4% trypan blue (Sigma Aldridge Corporation, St
Louis, Missouri, USA) for 60 s prior to viewing with an upright
stereomicroscope. Samples were excluded from experimentation
if they failed to meet the quality standards applied in our eye
bank for transplant grade tissue; if there were large areas of cell
loss; if there were >2% cell nuclei staining with trypan blue
and if there was excessive tissue folding with cell death.
Presence of guttae, central breaks in DM, positive donor ser-
ology and signs of media contamination also resulted in tissue
exclusion.
Media composition
Grafts were either stored in standard eye bank organ culture
ﬂuid (CorneaMax, Eurobio, Courtaboeuf, France) or stored in a
growth factor-containing enhanced medium (En-OC). The for-
mulation of En-OC was derived from preliminary experimenta-
tion in cultured porcine ECs (data not shown). The basal media
was composed of equal quantities of minimal essential medium,
Ham’s F-12, M199 (PAA Laboratories, GE Healthcare Life
Sciences, Pittsburgh, Pennsylvania, USA) and Optimem (Gibco,
Thermo Fischer Scientiﬁc, Waltham, Massachusetts, USA) and
supplemented with epidermal growth factor and basic ﬁbroblast
growth factor (10 ng/mL each, PeproTech, Rocky Hill,
Connecticut, USA), insulin/transferrin/selenium mix 1:200 (Life
Technologies), hydrocortisone (1 mg/mL), cholera toxin (100 ng/
mL) and chondroitin sulfate (1 mg/mL) (Sigma Aldrich).
Immunoﬂuorescence
Markers indicative of a structurally normal endothelium
(ZO-1), abnormal endothelial phenotype (α-smooth muscle
actin (SMA)) and proliferating cells (Ki-67) were selected.
ZO-1 or α-SMA staining was performed with 1:300 diluted
mouse antibody (Life Technologies, Carlsbad, California, USA).
Ki-67 staining was performed using 1:400-dilution rabbit Ki-67
antibody (Sigma Aldrich). Actin staining was performed with 1:400
diluted AlexaFluor 488-conjugated phalloidin. Cy3-conjugated
donkey anti-mouse IgG and AlexaFluor 488-conjugated goat anti-
rabbit IgG (1:1000) were used as secondary antibodies (Life
Technologies). Hoechst 33342 10 mM was used as a nuclear coun-
terstain (Life Technologies).
Figure 1 Flow diagram outlining the sequence of experimentation.
The ﬁrst experiment comparing storage media showed marked cell
overgrowth with enhanced organ culture media making it unsuitable
for use in Descemet’s membrane endothelial keratoplasty (DMEK)
storage. In the second experiment, DMEK grafts were returned to
standard organ culture after preparation and were evaluated for
features of abnormal cell overgrowth onto the stromal surface of the
DM. Peeling and laying back on the stroma was associated with rapid
cell overgrowth with endothelial-to-mesenchymal transformation and so
was deemed unsuitable as a method for storing DMEK grafts. The
other two preparation methods (bubble separation and storage as a
free scroll) did not show overgrowth at 4 days post-preparation and
global cell density assessment was performed using paired corneas.
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The DMEK scrolls were removed from culture, washed in
balanced salt solution (BSS) and ﬁxed in 1% paraformaldehyde
at room temperature for 5 min. Samples were permeabilised in
Triton-X 1% for 5 min, blocked in bovine serum albumin for
30 min and incubated with primary antibody at 4°C for
24 hours. Samples were washed three times with phosphate-
buffered saline and then incubated with secondary antibody and
Hoechst 33258 overnight at 4°C. To assess speciﬁcity of the
immunostaining, corneas were processed without primary anti-
body. DMEK specimens were ﬂat-mounted in anti-fading
mounting medium (Prolong Gold, Invitrogen) and whole mount
images were acquired using the Nikon Eclipse Ti-E inverted
ﬂuorescence microscope (Nikon, Tokyo, Japan) and exported to
ImageJ (National Institutes of Health, Bethesda, Maryland,
USA) for analysis.
Graft preparation techniques
We have previously described how we perform these techniques
in detail.14
Free scroll preparation
Manual peeling was performed on the punch block of a stand-
ard trephine (Coronet, Network Medical, UK). After 360° per-
ipheral scoring with a Sinsky hook, the DM/endothelium
complex was peeled halfway, laid back ﬂat and punched with an
8 mm trephine. The graft was then re-grasped, completely sepa-
rated from the stroma and rinsed gently in BSS. Grafts were
stored in a 24-well dish, lying on a glass cover slip to simulate
storage in a glass phial.
Partially peeled with storage on the stroma
As with full peeling, peripheral scoring followed by partial
peeling and trephination were performed. After trephination,
the graft was re-grasped and peeled until only a small peripheral
hinge of tissue remained (at least 90% of tissue peeled). The
graft was then reapposed to the stroma using a ‘no-touch’ tech-
nique by wicking away ﬂuid with a cellulose sponge. If sufﬁcient
ﬂuid was removed from under the graft, it stayed apposed to the
stroma after return to culture.
Fluid bubble separation
For ﬂuid bubble separation, a 25-gauge needle was inserted
underneath the trabecular meshwork (TM) and as close to DM
as possible. Organ culture ﬂuid was injected until a separation
between the DM and stroma occurred (seen as a small periph-
eral ‘bubble’) and was continued until it extended to the TM in
all areas. Once complete separation of the DM had been
achieved, the needle was passed through the stroma and into
the bubble space. Fluid was then withdrawn, allowing the
bubble to collapse, reapposing DM to the corneal stroma. The
corneas were placed endothelium up in a 6-well-dish containing
6 mL of organ culture ﬂuid. The grafts were punched using an
8 mm trephine immediately prior to assessment.
Determination of wound healing and proliferative capacity
in DM separated from the stroma
The corneal button was initially divided into two equal halves.
A standardised 1 mm endothelial wound was produced across
the centre of the cornea and perpendicular to the cut edge using
a silicone-tipped cannula, similar to the method previously
described in quartered corneas (ﬁgure 2A).29 Subsequently,
DMEK scroll preparation was performed using the standard
peel technique described earlier. Scrolled hemi-grafts were
washed in BSS to remove any cellular debris, were placed in
organ culture and were incubated at 37°C for variable periods
ranging from 2 to 8 days. One half-scroll from each cornea was
stored in standard culture media and the other half-scroll in
En-OC, allowing for direct comparison of the effect of the dif-
ferent media on samples from the same donor. Samples were
removed from culture at 2, 4, 6 and 8 days (n=3 at each time
point) and were ﬁxed. The area of DM not cover by cells was
manually outlined and measured using ImageJ and divided by
the starting wound area to calculate the percentage wound
healing. Having determined the time necessary for full wound
closure, three further corneas were analysed at day 4 (in total
n=6). ECD and the percentage of Ki-67-positive (proliferating)
cells were compared between wounded and unwounded areas
and between the two different media.
Assessment of EC overgrowth
Due to the limited availability of human corneal tissue, initial
assessments were performed in divided samples (n=2 at each
time point) for methods involving peeling. Corneal buttons
were divided into quadrants using a scalpel. One quarter from
each cornea was used for each of the ﬁrst three groups. In the
ﬁrst group, DM was stripped completely and placed into stand-
ard culture media in a 48-well plate. In the second group, the
same preparation procedure was performed but stripped DMs
were placed in En-OC. In the third group, the DM was peeled
90% off in each quadrant and then laid back onto the stroma
prior to storage. Experiments were repeated using six whole
corneas for each group (n=2 at each time point). As bubble
storage can only be performed with whole corneas, eight whole
grafts were used to assess this method (n=2 at days 2 and 4,
n=4 at day 8). Media was changed every 48 hours. Samples
were removed and ﬁxed at 2, 4 and 8 days and were stained
with phalloidin and either ZO-1 or α-SMA. Each sample was
carefully examined under the ﬂuorescence confocal microscope
for signs of endothelial migration onto the stromal surface.
Samples were classiﬁed as positive for overgrowth if any whole
cells could be seen migrating onto the stromal surface of the
DM (cells were usually continuous with the endothelial mono-
layer and could be seen to wrap around the trephined edge of
the graft).
Global ECD assessment
Based on the ﬁndings of the cell overgrowth experimentation,
grafts stored as free scrolls and after ﬂuid bubble preparation
were taken forward for global viability assessment (n=8 in each
group). Grafts in both groups were stored for 4 days in standard
organ culture ﬂuid at 37°C prior to global viability assessment.
Fluorescence-based viability assessment
Each sample was covered with 250 μL of BSS containing
Hoechst 33342 (10 μM), ethidium homodimer-1 (4 μM) and
calcein-AM (2 μM) (Life Technologies) and was incubated at
37°C for 30 min prior to mounting on a customised curved
viewing chamber. A Z-stack of 20–40 images was captured and
in-focus information from each image was combined to enhance
the depth of focus. Multiple image tiles were stitched together
and individual cell viability assessment was performed across the
entire graft surface using ImageJ (NIH, Bethesda, Maryland,
USA). The total number of viable cells was divided by graft area
(which had been corrected for imaging a curved surface) to cal-
culate a global ECD. To control for differences in initial ECD,
global ECD after storage was expressed as a percentage of eye
bank-recorded specular central ECD (‘corrected global ECD’).
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Analysis
Images and numeric data were collated using a Filemaker Pro
database (Apple, Cupertino, California, USA). Statistical com-
parisons were performed using Graphpad Prism (GraphPad
Software, La Jolla, California, USA) using two-tailed t-tests with
a threshold for statistical signiﬁcance set at p<0.05.
RESULTS
Wound healing assessment
The 1 mm wound had fully closed after 4 days in all corneas,
in both standard organ culture and EN-OC (ﬁgure 2A). At
day 2, the area of the wound not covered by the migrating
cells was smaller in the En-OC group than in the standard
organ culture group (39±7% vs 31±11%, n=3), but this
failed to reach statistical signiﬁcance. Evidence of EC prolifer-
ation was observed in most stored samples, but in general it
was limited to the wound site and the areas of trephination
damage (ﬁgure 2B).
Approximately 1% of all cells were Ki-67 positive with no
difference in proliferative capacity observed with the use of
En-OC. No Ki-67 positivity was seen in control samples ﬁxed
immediately after peeling without return to culture. Average
ECD in the wounded areas was approximately half of the
unwounded areas in both standard media (719±150 vs 1364
±170 cells/mm2, p<0.001, n=8) and En-OC (863±166 vs
1540±209 cells/mm2, p<0.001, n=8). There was a trend
towards higher ECD in the wounded areas of grafts stored in
En-OC (863±166 vs 719±150, p=0.09, n=8) (see online sup-
plementary table S1).
Endothelial overgrowth
The only storage method free from endothelial overgrowth was
ﬂuid bubble separation. No grafts stored as free scrolls in stand-
ard media had endothelial migration at day 4 but 50% showed
this phenomenon at day 8. Endothelial overgrowth was more
rapid and extensive in peeled tissue stored in growth factor-
enhanced En-OC storage media, with migrating cells observed
in all samples at day 2 and completely covering the stromal
surface of graft by day 8. Overgrowth also occurred more
quickly in grafts in which DM was incompletely peeled and laid
back on the stroma with overgrowth seen in 50% of the samples
by day 2 (see online supplementary table S2). Overgrowing cells
in the samples stored laying on the stroma or incubated with
growth factor-enhanced En-OC media lost junctional staining
Figure 2 (A) Photomicrograph
showing a Descemet’s membrane
endothelial keratoplasty (DMEK) graft
from half a cornea. A standard injury is
created with a silicon-tipped cannula
(white lines). After 4 days in standard
organ culture media, the wound has
been completely covered by migrating
endothelial cells. Cell density in the
unwounded (*) area is much higher
than in the wounded area (**). Tight
junctions are not fully formed at 4 days
in the wound area (ZO-1 in red). Scale
bar 100 mm. (B) Half DMEK grafts
were stained for makers of
proliferation. Upper panel: Endothelial
cells in unwounded areas of the half
DMEK graft preserve a healthy, mature
monolayer, conﬁrmed by a normal
staining for ZO-1. No Ki-67-positive
(proliferating) cells are seen. Lower
panel: Image taken from the wound
site. Ki-67-positive nuclei (green) and
cells in various stages of mitosis (white
arrows) are seen. In spite of
proliferation, cell density remains lower
than in the unwounded areas. Scale
bar 50 mm.
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for ZO-1, had an increased number of actin stress ﬁbres and
stained positively for α-SMA (ﬁgure 3). Migrating ECs in the
free scroll group retained a more ‘endothelial’ morphology with
a rounded shape and fewer stress ﬁbres.
Global ECD
As excessive and early endothelial overgrowth was observed
when DM grafts were partially peeled and laid back onto
corneal stroma, this method was excluded from global endothe-
lial viability assessment in transplant grade tissue. After 4 days in
culture, global viable ECD was signiﬁcantly higher in the free
scroll donors than in the ﬂuid bubble grafts (table 1).
Qualitative assessment of cell death and endothelial
morphology
Characteristic and reproducible patterns of cell death were seen
in both groups. In the free scroll group, linear patterns of cell
death aligned with the long axis of the scroll were seen in all
samples (ﬁgure 4A–C). In the bubble group, areas of cell death
were frequently seen at peaks of tissue folds that had occurred as
ﬂuid reaccumulated between the DM and stroma (ﬁgure 4D–F).
Normal tight junction and actin staining patterns were
observed in the healthy areas of graft from both groups, with no
discernible differences between the two storage methods.
Irregular staining was observed in areas of cell death and those
adjacent to them.
DISCUSSION
As more surgeons adopt DMEK, there is an increasing interest
in the delivery of pre-stripped DMEK donor tissue. The optimal
storage method for pre-stripped grafts should maximise global
graft viability, encourage areas of preparation damage to heal
and ensure that the ECs are phenotypically normal.
A process of wound healing occurs in DMEK grafts that are
returned to organ culture. A 1 mm wound (which is relatively
large compared with typical hypotony-induced linear areas of
cell death) heals in approximately 4 days. As with whole
corneas, the process of wound healing occurs primarily by cell
spreading with low-level mitosis limited to areas of wound-
ing.29 30 Cell density is signiﬁcantly lower in the wounded area
as compared with the surrounding unwounded areas showing
that any proliferation is insufﬁcient to restore the pre-wounding
cell density.
Use of En-OC showed a trend towards increased cell density
in the wounded area but it does not increase cell proliferation,
as detected by Ki-67 staining, suggesting that the effect of
growth factor supplementation is to primarily increase cell
migration. The effect of growth factor supplementation in
whole corneas is uncertain, with some studies showing minimal
cell proliferation,31 while other reports suggest that signiﬁcant
levels of mitosis may occur.29 32 Differences in donor age, cell
Figure 3 (A) Fluorescence image showing whole Descemet’s
membrane endothelial keratoplasty (DMEK) graft that has been peeled,
laid back on to the stroma and stored for a further 4 days in standard
organ culture media. The graft had been stained with phalloidin
(green). *Enlarged segment from a central portion of the graft showing
a healthy, hexagonal endothelial monolayer, with a normal actin
staining pattern. **Enlarged segment from the periphery of the graft is
shown. Large endothelial cells have migrated onto the stromal surface
of the DM, with an out-of-focus layer of normal endothelial cells seen
underlying these cells on the correct side of the DM. Cells have
enlarged, ﬂattened and acquired multiple linear stress ﬁbres, indicating
endothelial-to-mesenchymal transformation. (B) A confocal image of
the migrating cells shows positive staining for α-SMA, a marker for
endothelial-to-mesenchymal (red). Scale bars 50 mm.
Table 1 Graft characteristics and post-storage ‘corrected ECD’ in grafts stored as collapsed bubbles or free scrolls
Free scroll OD (n=8) Liquid bubble OS (n=8) p Value
Donor age 65.4±10.3 years 65.4±10.3 years
ECD±SD (specular) 2667±221 cells/mm2 2754±200 cells/mm2
Death to storage time 6.2±4.1 hours 6.2±4.1 hours






Donors with diabetes 1 (in myocardial infarction group) 1 (in myocardial infarction group)
Corrected graft area±SD 58.1±0.51 mm2 59.4±0.73 mm2
Corrected global ECD±SD 74.2±3% 60.3±6% 0.035
Tissue was from paired donors. Global viability was calculated by counting all viable cells on the graft and dividing this value by the graft area (adjusted for imaging a spherical cap).
This figure was presented as a percentage of the starting central ECD measured in the eye bank – corrected global ECD.
ECD, endothelial cell density; OD, oculus dexter; OS, oculus sinister.
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density or pre-experimentation storage duration may account
for the variations reported.33
In peeled and trephined grafts stored in the En-OC media,
endothelial migration onto the stromal surface of DM occurred
rapidly. While ECs on the anatomically correct side of DM
maintained a normal phenotype (cortical actin staining pattern
and ZO-1 expression at cell borders), cells migrating onto the
stromal side lost ZO-1 expression, enlarged, ﬂattened and had
multiple pseudopodia. The cells had extensive actin stress ﬁbres
and stained positively for α-SMA. These features are suggestive of
endothelial-mesenchymal transformation (EMT).34 Endothelial
migration with a similar phenotype was seen in grafts peeled
and laid back against the stroma, being observed as early as
2 days after return to culture. In free scrolls, migration was not
observed in any grafts at day 4 post-preparation but was seen in
grafts stored for longer periods to time, supporting the hypoth-
esis that growth factors, either added to the media or released
from the stroma, increased migration speed. In the bubble separ-
ation group, a physical barrier to migration is preserved, pre-
venting overgrowth from occurring.
An EMT phenotype has been observed in some failed DMEK
grafts and is associated with graft detachment and opacity.35 36
Multi-layered, transformed ECs have also been observed in ret-
rocorneal membranes in animal models of endothelial wound-
ing.37 We were concerned to observe this phenomenon in
DMEK donors stored in enriched media or in apposition to the
Figure 4 (A) A branching pattern of cell death, staining positively with trypan blue and corresponding to tissue folds, is seen immediately after
preparation. (B) Scrolled graft is shown laying on a glass cover slip in a 48-well culture dish. (C) Global endothelial viability assessment showing
characteristic lines of cell death corresponding to the long axis of the scroll. (D) Trypan blue staining immediately after bubble separation shows
patterns of cell death consistent with tissue folds. (E) Trypan blue staining after tissue storage shows death cells at the peaks of tissue folds. (F)
Global endothelial evaluation of bubble separated graft after trephination.
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stroma. It is unclear why cells migrating on the stromal surface
of DM acquire a different phenotype to those migrating within
healing wounds on the endothelial surface. Ichijima et al38 used
two different terms for the behaviour of ECs following mechan-
ical scraping and cryo-injury, cell spreading (collective cell move-
ment with relative preservation of a normal EC phenotype) and
cell migration (movement of mesenchymally transformed ECs),
respectively.39 These processes are seen both in-vivo and
ex-vivo37 40 and, in other disease models, it can occur concur-
rently within the same microenvironment.41 In the samples we
stored as peeled grafts laid back on the stroma or as free scrolls
in enhanced organ culture media, cell spreading predominated
in the wounded areas of the endothelial surface of the DM,
whereas cell migration with loss of the normal phenotype pre-
dominated within the areas of overgrowth onto the stromal
aspect of DM. In free scrolls, cell spreading predominated on
both sides of DM over the time period examined.
It is possible that cell density and the time period to restor-
ation of contact inhibition determine cell fate. On the endothe-
lial surface of DM, in transplant grade tissue, cells re-establish
contact reactively quickly and preserve normal borders on the
non-migrating edge. On the stromal surface of DM, cells detach
and migrate. Now unable to re-establish normal contact inhibi-
tion the cells produce numerous extensions and there is a loss
of normal phenotype. These observations correspond with EC
culture experiments showing a correlation between the ﬁbrotic
phenotype and low seeding density.42 We witnessed a density-
dependent alteration in cell phenotype when one specimen with
extensive cell loss was returned to storage (see online supple-
mentary ﬁgure S1). In this specimen we observed an increasing
derangement of the normal phenotype as cell density dropped,
suggesting that cell density may also control cell fate in ex-vivo
organ culture.
EC migration off DM in divided whole corneas has been
reported before,33 but EC migration onto the stromal side of
DM has not been reported in DMEK donor tissue. Lie et al27
showed that repair of the trephination-induced damage area
occurred in stored DMEK grafts; however, this was only exam-
ined using bright ﬁeld microscopy, precluding any assessment of
the relative contribution of cell division and spreading, and
migration of ECs onto the stromal surface of the DM was not
described.
As a period of 4 days is sufﬁcient to prepare and distribute
transplant tissue in most circumstances, we would recommend
4 days as a time limit for re-storage after scroll preparation for
DMEK scrolls stored in standard organ culture conditions. Any
alterations to media need careful testing speciﬁcally with DMEK
tissue to deﬁne the safe time window for re-storage before new
protocols are implemented clinically. Our enhanced En-OC
media did not induce signiﬁcant donor cell regeneration and
does not seem beneﬁcial for short-term storage of DMEK
donors. Enhanced media may be useful if combined with the
bubble separation method of DMEK preparation as a physical
barrier to cell migration is preserved in this instance.
We previously found that a peeling technique is associated with
less damage to the endothelium than bubble separation using
our global corneal viability assessment method.14 However, a
further reduction of approximately 20% in global ECD after
storage was observed here in both groups, which is consistent
with some other reports of DMEK storage.26 Storage of the DM
in close proximity to the stroma failed to show any survival
beneﬁt, in keeping with the results of the grafts stored in
enhanced media, suggesting that co-culture in proximity to other
corneal cell types confers no survival beneﬁt in the short term.
Areas of cell death conformed to characteristic patterns in
both groups, with surrounding cells displaying changes in actin
staining patterns. We suggest that a change in graft conformation
induces a different pattern of mechanical stress, with new hot-
spots of cell death occurring at sites of maximal tension, similar
to the mechanism thought to underlie cell death at corneal
folds.12 In pilot experiments, we observed less cell death in
corneas in which the partially peeled DM had been laid back on
the stroma, thus maintaining a normal anatomical orientation.
However, this storage method resulted in rapid endothelial
migration and transformation, contaminating the stromal
surface of DM. A method or device allowing maintenance of a
normal DM curvature free from storage with the stroma may
prevent the new patterns of cell loss we observed.
DMEK transplants stored in organ culture undergo a dynamic
process of wound healing and ongoing cell death. Cell loss predo-
minates and new patterns of cell death emerge as the mechanical
forces placed on the ECs change. Methods for tissue preparation
and storage developed for whole corneas should not be used in
pre-prepared DMEK grafts without prior evaluation. Further
work evaluating the storage of pre-prepared DMEK grafts in cold
storage media is warranted as the process of EC healing and
migration are known to be different than in organ culture.43
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